Skip to content

A prospective study of evaluating a safety of endoscopic ultrasound-guided fine needle aspiration in patients with antithrombotic agents

A prospective study of evaluating a safety of endoscopic ultrasound-guided fine needle aspiration in patients with antithrombotic agents - A safety of EUS-FNA in patients with antithrombotic agents

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008998
Enrollment
100
Registered
2012-10-01
Start date
2012-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lesions with Indication for EUS-FNA

Interventions

None listed

Sponsors

Hokkaido University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, Age >20 2, Patients with high risk for thromboembolic event 1)within 2 months after coronary artery stent placement 2)within 12 months after coronary artery drug eluting stent placement 3)within 2 months after cerebral vascular surgery 4)cerebral infarction with stenosis in main artery more than 50% 5)Past history of cerebral infarction and transient ischemic attack 6)ASO with pain during rest 7)past history of cardiogenic cerebral infarction 8)atrial fibrilation with valvular disease 9)atrial fibrilation in patients with high risk for cerebral infarction 10)patients with mechanical heart mitral valve replacement 11)past history of cerebral infarction with mechanical heart valve replacement 12)antiphospholipid syndrome 13)deep venous thrombosis and pulmonary thromboembooism 3, written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1, PS 4 2, ASA >3 3, Pregnancy 4, contraindication for endoscopy 5, Platelate count < 50000/m3 6, PT-INR >2.0 7, EUS-FNA for cystic lesion

Design outcomes

Primary

MeasureTime frame
A rate of bleeding complication

Countries

Japan

Contacts

Public ContactMidori Nishioka

Hokkaido University Hospital IRB

midorin@med.hokudai.ac.jp011-706-7636

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026